Navigation Links
Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
Date:8/12/2008

cost to the patient).

1Matheson R, Kempers S, Breneman D, et al. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects. J Drugs Dermatol. 2008; 7:266-271.
2 http://www.niams.nih.gov/Health_Info/Atopic_Dermatitis/default.asp#link_b
3 Fowler JF Jr. Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitis. Cutis 2005; 75:125-131.

For more information on Locoid® Lotion for adult to pediatric patients with atopic dermatitis, please contact Peter Volk or Aleen Hosdaghian of Triax Pharmaceuticals, LLC, 908.372.0500.
See www.locoid.com for full prescribing information.

# # #

Read the full story at http://www.prweb.com/releases/2008/08/prweb1190714.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid  Lotion 0.1% 
Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
(Date:11/9/2009)...ment, study finds , , MONDAY, Nov. 9 (He...r left atrial enlargement, which increases the ris...study shows. , Atrial fibrillation is the most ...hm or heartbeat). , Researchers analyzed data ...who were followed for 10 years. The study authors ...
(Date:11/9/2009)...ing is everybody,s buzz word today and for Recruit...enables Recruiters and Staffers create their own p...unicate and close positions. The site also enables... network with recruiters. , ...forces everyone to network more than ever and by t...
(Date:11/9/2009)...nces in mood despite similar weight loss , ...h-fat, low-carbohydrate diet such as the popular A... to help people lose pounds over the course of a y... will result in long-term improvement in mood, acc... of Internal Medicine . , People on both diets ...
(Date:11/9/2009)...Newswire-FirstCall/ - Hard To Treat Diseases (HTDS...ovartis, a US$41 billion international healthcare ...accine partner, Zhejiang Tianyuan Bio-Pharmaceutic...zerland will begin a five-year, $1 billion China i...ally increase its investment in its China R&D ...
(Date:11/9/2009)... to be Offered in April 2010, Provides First Respo... Cambridge, MA (Vocus) November 9, 2009 -- W...(PHR) first inspected a suspected mass grave at D... need a team of experts to help interpret the scen...a key first step in securing evidence of a human r...
Breaking Medicine News(10 mins):Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
...LLINGTON, Fla., July 8 The Quantum Group,(Amex: ...hat Renaissance Health,Systems, a Quantum subsidia...tate of Florida, with a new statewide payer (healt...orida where,Renaissance has established Community ...
...nt of Breast Cancer Patient,s HER2 ...FRANCISCO, Calif., July 8 Monogram,Biosciences, I...ve July 15,the HERmark(TM) Breast Cancer Assay wil...tive measurement of HER2,total protein and HER2 ho...
...onal Postgraduate Services® (PPS®), renown...unces the launch of an on-demand, interactive case...herapeutic Options for Mid-Face Volumizing, now av...ing. This valuable continuing medical education (C...
...com, the online leader in providing the complete r...nced the release of a new line of printable plasti...rganization to print laser membership cards and la... Ft. Scott, KS (PRWEB) July 8, 2008 -- My...
...Incorporated (Nasdaq: ARAY ), a global leader in ...will report results for its fourth quarter and,fis...ugust 19, 2008 after,the market closes., A confer...e officer and Robert E. McNamara, senior vice pres...
...tension journal suggests that increasing, dietar... prevention of hypertension, a major ...are good sources of potassium and low in sodium ...l Hypertension,concludes that an increase in potas...
Other Medicine News:Health News:The Quantum Group Expands Payer Partnerships 2Health News:The Quantum Group Expands Payer Partnerships 3Health News:Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay 2Health News:Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay 3Health News:Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay 4Health News:Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay 5Health News:Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay 6Health News:AestheticEnhance.org Launches CME-Certified Case Study on Mid-Face Volumizing 2Health News:AestheticEnhance.org Launches CME-Certified Case Study on Mid-Face Volumizing 3Health News:My1Stop.com Enables Desktop Printing of Plastic Laser Membership Cards, or Realcard, and Laser Insurance Cards 2Health News:Accuray Incorporated to Report Fourth Quarter and Fiscal Year 2008 Financial Results 2Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 2Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 3Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 4Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 5
(Date:11/9/2009)...OriGene Technologies, Inc. today announced Royal I...ERIFY Tagged Antigen(TM) (Over-expression Lysates)...is funded by the Knut and Alice Wallenberg Foundat...stematically using Antibody-Based Proteomics. "Gen... high throughput manner is critical for the succes...
(Date:11/9/2009)... -- TessArae® LLC, a global leader in reseque... launch of new integrated product solutions for ge... hereditary diseases. The combination of TessArae... novel nucleotide sequence basecalling algorithms ...rgeted mutations in multiple genes of a syndrome o...
(Date:11/9/2009)...wire/ -- On Sept. 11, 2001, thousands of firefig...me together to save as many lives as possible in N...as one of those 9/11 first responders. Now he is f...te 30s, McCauley was diagnosed with cancer in 2006...apy treatments, leaving him confined to a wheelcha...
Breaking Medicine Technology:Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2TessArae Delivers Lower Cost Option to Genetic Testing Market 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic 47443 1Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic 47443 2PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 1PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 2PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 3Religious devotion does not impact abortion decisions of young unwed women 47440 1Religious devotion does not impact abortion decisions of young unwed women 47440 2
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) annou...e a corporate overview of its clinical development...conferences: -- ThinkEquity Partners, 5th Annual ...ber 17, 2007 at 10:00 a.m. Pacific Time (1:00 ...rancisco Presenting: Jack Lief, Arena,s Presid...
...s to Educate Women About this Common Condition, M...ill,be at the Hyatt Regency Milwaukee hotel (333 W... from 6:30 pm to 7:30 pm to talk about her,experie... is speaking as,part of What,s Happening Down Ther...education campaign. Area residents are invited to ...
Other Medicine Technology:Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences 2Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences 3Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 2Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 3
...compatible with multichannel pipettors, which allo...tting steps required to prepare and place the pati...cepts for more information about this procedure an... an * after the catalog number and are available i...
...that has been genetically engineered to increase t...affecting the other ANA patterns seen. Several ind...the HEp-2000 ANA substrate, which show increased s...place of standard HEp-2 cells as the routine ANA s...
...out patients negative for antinuclear antibodies, ...ic diseases such as Systemic lupus erythematosus (... disease, progressive systemic sclerosis, sclerode...phenomenon. They can also be used in conjunction w...
...out patients negative for antinuclear antibodies, ...ic diseases such as Systemic lupus erythematosus (... disease, progressive systemic sclerosis, sclerode...phenomenon. They can also be used in conjunction w...
Medicine Products: